Clinicopathological significance of the CRTC3–MAML2 fusion transcript in mucoepidermoid carcinoma
- 1 December 2009
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 22 (12), 1575-1581
- https://doi.org/10.1038/modpathol.2009.126
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A new type of MAML2 fusion in mucoepidermoid carcinomaGenes, Chromosomes and Cancer, 2007
- CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: Implications for histogenesis and biologic behaviorGenes, Chromosomes and Cancer, 2007
- MECT1-MAML2 Fusion Transcript Defines a Favorable Subset of Mucoepidermoid CarcinomaClinical Cancer Research, 2006
- Molecular classification of mucoepidermoid carcinomas—Prognostic significance of the MECT1–MAML2 fusion oncogeneGenes, Chromosomes and Cancer, 2006
- Mect1-Maml2 Fusion Oncogene Linked to the Aberrant Activation of Cyclic AMP/CREB Regulated GenesCancer Research, 2005
- Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activationThe EMBO Journal, 2005
- Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumorsExperimental Cell Research, 2004
- Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathwayNature Genetics, 2003
- A mucoepidermoid carcinoma of minor salivary gland with t(11;19)(q21;p13.1) as the only karyotypic abnormalityCancer Genetics and Cytogenetics, 1996